Please join the Council’s Anita Garg and fellow presenters as they explore the strategic, ethical, and practical considerations that contraceptive developers and funders weigh when deciding how and when to share information about innovative contraceptive leads and products. From protecting intellectual property to building public trust and securing funding, the decision to disclose—or delay—can shape the trajectory of a product and its impact.
Moderator: Andrée Sosler, FHI 360
Panelists:
- Akash Bakshi, Chief Executive Officer, YourChoice Therapeutics
- Anita Garg, Senior Director of Strategy & Commercial Relations, Population Council
- Liz Proos, Vice President of Product Development, Daré Bioscience